Evidence map›Paper›PMID 39819738›Full record

ArticleBiology of sex differences2025

Age- and sex-specific differences in myocardial sympathetic tone and left ventricular remodeling following myocardial injury.

Achi Haider, Susan Bengs, Angela Portmann, Sandro Fröhlich, Dominik Etter, Monika Maredziak, Geoffrey I Warnock, Alexander Akhmedov, Sebastian Kozerke, Claudia Keller and 9 more

Abstract read
In one paragraph

Article in Biology of sex differences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. In vitro sex-specific function-structure relationship in neonatal rat cardiac monolayers.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Achi Haider *Department of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Susan Bengs *Department of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Angela PortmannDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Sandro FröhlichDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Dominik EtterDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Monika MaredziakDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Geoffrey I WarnockDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Alexander AkhmedovCenter for Molecular Cardiology, University of Zurich, Schlieren, CH-8952, Switzerland.
Sebastian KozerkeInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, CH-8092, Switzerland.
Claudia KellerInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, CH-8093, Switzerland.
Fabrizio MontecuccoFirst Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, Genoa, 16132, Italy.
Bruno WeberInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, CH-8057, Switzerland.
Linjing MuDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Ronny R BuechelDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Vera Regitz-ZagrosekInstitute for Gender in Medicine, Charité Universitaetsmedizin Berlin, Berlin, D-10115, Germany.
Philipp A KaufmannDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland.
Giovanni G CamiciCenter for Molecular Cardiology, University of Zurich, Schlieren, CH-8952, Switzerland.
Simon M AmetameyInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, CH-8093, Switzerland.
Catherine GebhardDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, CH-8091, Switzerland. catherine.gebhard@insel.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPresentations and outcomes of acute myocardial infarction (MI) differ between women and men, with the worst outcomes being reported in younger women. Mental stress induced ischemia and sympathetic activation have been suggested to play a prominent role in the pathogenesis of MI in younger women, however, the impact of sex hormones on these parameters remains unknown.

methodsThe effect of sex hormones and age on myocardial infarct size and myocardial sympathetic activity (MSA) was assessed in male and female, as well as young (4-6 months) and aged (20-22 months) FVB/N mice (n = 106, 60 gonadectomized and 46 sham-operated animals) who underwent in vivo [

resultsMSA and catecholamine levels following myocardial injury were highest in young males (p = 0.008 and p = 0.043 vs. young females, respectively) and were reduced by orchiectomy. Accordingly, testosterone serum levels correlated positively with MSA (r = 0.66, p < 0.001). Males had a larger average infarct size and lower left ventricular contractility following myocardial injury than females (p < 0.05 vs. females). These sex differences were no longer evident in gonadectomized animals (p = NS vs. females). In female animals, estrogen depletion did not affect MSA (ovariectomy effect, p = 0.892). Female animals showed an age-dependent increase in MSA (p = 0.011), which was absent in males.

conclusionTestosterone associates with an increase in sympathetic tone, contributing to adverse cardiac remodeling following MI. Conversely, females maintain sympathetic integrity, independent of sex hormones. Our results suggest a biological advantage of female sex in post MI recovery. Further research is warranted to confirm these findings in humans.

Indexed as

AgingHeartMyocardial InfarctionSex CharacteristicsSympathetic Nervous SystemVentricular RemodelingAge FactorsAnimalsFemaleMaleMiceMyocardiumPositron-Emission TomographyTestosteroneTestosterone[11C]meta-hydroxyephedrineCardiac magnetic resonance (CMR) imagingMyocardial infarctionPositron emission tomography (PET)SexSex hormones

Identifiers

PMID39819738
PMCPMC11737239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.